Literature DB >> 23634683

Perioperative outcome in dogs with hemoperitoneum: 83 cases (2005-2010).

Cassie N Lux1, William T N Culp, Philipp D Mayhew, Kim Tong, Robert B Rebhun, Philip H Kass.   

Abstract

OBJECTIVE: To characterize the clinical course of dogs with hemoperitoneum in the perioperative setting and to determine risk factors that may affect short-term outcome.
DESIGN: Retrospective case series. ANIMALS: 83 client-owned dogs. PROCEDURES: The medical records of dogs with hemoperitoneum that underwent surgery between 2005 and 2010 were reviewed. Data were analyzed to determine risk factors associated with perioperative outcome. The perioperative period was defined as the time from admission to the hospital for treatment of hemoperitoneum until the time of discharge or euthanasia (within the same visit).
RESULTS: 13 of 83 (16%) dogs died or were euthanized in the perioperative period. The median hospitalization time for surviving dogs was 2 days (range, 1 to 5 days). The requirement for a massive transfusion with blood products was a negative prognostic indicator for hospital discharge. The source of bleeding was isolated to the spleen in 75 of 83 (90%) dogs; a splenic source of hemorrhage was determined to be a positive predictor of survival to discharge from the hospital. CONCLUSIONS AND CLINICAL RELEVANCE: In the present study, factors associated with death and failure to be discharged from the hospital included tachycardia, a requirement for massive transfusion with blood products, and the development of respiratory disease secondary to suspected pulmonary thromboembolism or acute respiratory distress syndrome. The presence of disease within the spleen was positively associated with survival to discharge. Surgical intervention for treatment of hemoperitoneum, regardless of etiology, resulted in discharge from the hospital for 70 of the 83 (84%) dogs in this series.

Entities:  

Mesh:

Year:  2013        PMID: 23634683     DOI: 10.2460/javma.242.10.1385

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Resuscitation Patterns and Massive Transfusion for the Critical Bleeding Dog-A Multicentric Retrospective Study of 69 Cases (2007-2013).

Authors:  Claire Tucker; Anna Winner; Ryan Reeves; Edward S Cooper; Kelly Hall; Julie Schildt; David Brown; Julien Guillaumin
Journal:  Front Vet Sci       Date:  2022-01-05

2.  Pre-operative Hemostatic Status in Dogs Undergoing Splenectomy for Splenic Masses.

Authors:  Jourdan B McPhetridge; Alex M Lynch; Cynthia R L Webster; Emily McCobb; A M de Laforcade; Therese E O'Toole
Journal:  Front Vet Sci       Date:  2022-04-25

3.  Tissue-Welding Device: Considerable Advantages for Spleen Surgery Based on Histological and Cardiorespiratory Investigation.

Authors:  Linda Gatiņa; Inga Piginka-Vjaceslavova; Dace Bērziņa; Maksims Zolovs
Journal:  Vet Med Int       Date:  2022-09-24

4.  Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma.

Authors:  Alison R Masyr; Aaron K Rendahl; Amber L Winter; Antonella Borgatti; Jaime F Modiano
Journal:  J Am Vet Med Assoc       Date:  2021-03-15       Impact factor: 1.936

5.  Hypocoagulability and Platelet Dysfunction Are Exacerbated by Synthetic Colloids in a Canine Hemorrhagic Shock Model.

Authors:  Corrin J Boyd; Melissa A Claus; Anthea L Raisis; Giselle Hosgood; Claire R Sharp; Lisa Smart
Journal:  Front Vet Sci       Date:  2018-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.